US Bancorp
EVMN icon

US Bancorp’s Evommune Inc EVMN Stock Holding History

US Bancorp’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$157K Buy
+19,000
New +$228K ﹤0.01% 2201

Other funds holding EVMN

Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Andera Partners
Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Natixis
Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return

US Bancorp's EVMN Position: Q3 2026 in Review

US Bancorp opened a new position in Evommune Inc (EVMN) in Q3 2026: 19,000 shares worth $157K. The stake represents ﹤0.01% of the portfolio and ranks #2201 among its holdings.

27 funds tracked by Wall St. Rank hold EVMN as of Q3 2026.

  • US Bancorp held 19,000 shares of Evommune Inc worth $157K as of Q3 2026.
  • Evommune Inc was a new US Bancorp position in Q3 2026.
  • Evommune Inc made up ﹤0.01% of US Bancorp's portfolio in Q3 2026, its #2201 holding.
  • 27 funds tracked by Wall St. Rank held Evommune Inc as of Q3 2026.

Based on US Bancorp's 13F filing for Q3 2026, filed 5 Nov 2026.